Prostaglandin A(1) protects striatal neurons against excitotoxic injury in rat striatum.

Prostaglandin A(1) (PGA1) reportedly inhibits NF-kappaB activation and induces expression of heat shock proteins. Since both these effects could be neuroprotective, the therapeutic potential of PGA1 in neurodegenerative disorders, where excitotoxicity may contribute to pathogenesis, was evaluated in rat striatal neurons exposed to the N-methyl-D-aspartate (NMDA) receptor agonist quinolinic acid (QA). Intrastriatal administration of PGA1 (5-80 nmol) attenuated QA (60 nmol)-induced internucleosomal DNA fragmentation. The inhibitory effects of a single dose of PGA1 (80 nmol) on QA (60 nmol)-induced DNA fragmentation were observed 12 to 48 h after treatment. PGA1 (80 nmol) also attenuated QA-induced DNA fragmentation when administered up to 4 h after QA exposure. PGA1 significantly decreased the loss of D1 dopamine receptors and GAD(67) mRNA in QA-injected striatum as measured by quantitative receptor autoradiography and in situ hybridization histochemistry, suggesting that it reduced the neuronal loss induced by QA. Protection of striatal neurons against QA-induced death by PGA1 was further indicated by Nissl staining 10 days after QA administration. PGA1 (5-80 nmol) significantly inhibited QA-induced NF-kappaB activation by blocking inhibitory kappaB-alpha degradation but had no effect on activator protein-1 binding activity. PGA1 (80 nmol) treatment substantially increased 70- and 72-kDa heat shock protein levels in striatum. These results indicate that PGA1 blunts NMDA receptor-mediated neuronal apoptosis by a mechanism possibly involving the up-regulation of neuroprotective heat shock proteins and inhibition of NF-kappaB activation. In view of its potent neuroprotective activity, PGA1 could prove useful in the treatment of certain neurodegenerative disorders related to excitotoxicity.

[1]  Z. Qin,et al.  A caspase-3-like protease is involved in NF-kappaB activation induced by stimulation of N-methyl-D-aspartate receptors in rat striatum. , 2000, Brain research. Molecular brain research.

[2]  Z. Qin,et al.  Kainic Acid‐Induced Apoptosis in Rat Striatum Is Associated with Nuclear Factor‐κB Activation , 2000, Journal of neurochemistry.

[3]  G. Natoli,et al.  Anti-inflammatory cyclopentenone prostaglandins are direct inhibitors of IκB kinase , 2000, Nature.

[4]  T. Chase,et al.  Co-stimulation of cyclic-AMP-linked metabotropic glutamate receptors in rat striatum attenuates excitotoxin-induced nuclear factor-κB activation and apoptosis , 1999, Neuroscience.

[5]  Y. Tao,et al.  NF-κB functions as both a proapoptotic and antiapoptotic regulatory factor within a single cell type , 1999, Cell Death and Differentiation.

[6]  T. Chase,et al.  Nuclear Factor κB Nuclear Translocation Upregulates c-Myc and p53 Expression during NMDA Receptor-Mediated Apoptosis in Rat Striatum , 1999, The Journal of Neuroscience.

[7]  Markus Schwaninger,et al.  NF-κB is activated and promotes cell death in focal cerebral ischemia , 1999, Nature Medicine.

[8]  Claus Scheidereit,et al.  NF-κB Function in Growth Control: Regulation of Cyclin D1 Expression and G0/G1-to-S-Phase Transition , 1999, Molecular and Cellular Biology.

[9]  C. Justicia,et al.  Activation of nuclear factor-κB in the rat brain after transient focal ischemia , 1999 .

[10]  T. Chase,et al.  Free radical scavenger OPC-14117 attenuates quinolinic acid-induced NF-kappaB activation and apoptosis in rat striatum. , 1999, Brain Research. Molecular Brain Research.

[11]  David S. Park,et al.  Cyclin-dependent Kinases Participate in Death of Neurons Evoked by DNA-damaging Agents , 1998, The Journal of cell biology.

[12]  R. Sapolsky,et al.  Gene therapy with HSP72 is neuroprotective in rat models of stroke and epilepsy , 1998, Annals of neurology.

[13]  P. Han,et al.  Ca2+‐Mediated Activation of c‐Jun N‐Terminal Kinase and Nuclear Factor κB by NMDA in Cortical Cell Cultures , 1998, Journal of neurochemistry.

[14]  松浦 弘治.  Cyclosporin A attenuates the decrease in tyrosine hydroxylase immunoreactivity in nigrostriatal dopaminergic neurons and in striatal dopamine content in rats with intrastriatal injection of 6-hydroxydopamine , 1997 .

[15]  J. Simpkins,et al.  Role of estrogen replacement therapy in memory enhancement and the prevention of neuronal loss associated with Alzheimer's disease. , 1997, The American journal of medicine.

[16]  M. Mattson,et al.  Activation of NF‐κB protects hippocampal neurons against oxidative stress‐induced apoptosis: Evidence for induction of manganese superoxide dismutase and suppression of peroxynitrite production and protein tyrosine nitration , 1997, Journal of neuroscience research.

[17]  A. Joly,et al.  Cyclosporine A is an uncompetitive inhibitor of proteasome activity and prevents NF‐κB activation , 1997, FEBS letters.

[18]  Y Agid,et al.  Nuclear translocation of NF-kappaB is increased in dopaminergic neurons of patients with parkinson disease. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[19]  T. Garcia,et al.  Estrogen receptor impairs interleukin-6 expression by preventing protein binding on the NF-kappaB site. , 1997, Nucleic acids research.

[20]  B. Siesjö,et al.  Amelioration by cyclosporin A of brain damage following 5 or 10 min of ischemia in rats subjected to preischemic hyperglycemia , 1997, Brain Research.

[21]  P. Baeuerle,et al.  Transcription factor NF-κB is activated in primary neurons by amyloid β peptides and in neurons surrounding early plaques from patients with Alzheimer disease , 1997 .

[22]  David S. Park,et al.  G1/S Cell Cycle Blockers and Inhibitors of Cyclin-Dependent Kinases Suppress Camptothecin-Induced Neuronal Apoptosis , 1997, The Journal of Neuroscience.

[23]  A. Rossi,et al.  Inhibition of nuclear factor kappa B by prostaglandin A1: an effect associated with heat shock transcription factor activation. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[24]  M. Memo,et al.  Neuroprotection by Aspirin and Sodium Salicylate Through Blockade of NF-κB Activation , 1996, Science.

[25]  Seamus J. Martin,et al.  Suppression of TNF-α-Induced Apoptosis by NF-κB , 1996, Science.

[26]  T. Chase,et al.  Stimulation of N-methyl-d-aspartate receptors induces apoptosis in rat brain , 1996, Brain Research.

[27]  M. Mattson,et al.  Estrogens Attenuate and Corticosterone Exacerbates Excitotoxicity, Oxidative Injury, and Amyloid β‐Peptide Toxicity in Hippocampal Neurons , 1996, Journal of neurochemistry.

[28]  T G Cotter,et al.  Heat shock proteins increase resistance to apoptosis. , 1996, Experimental cell research.

[29]  A. Zantema,et al.  Cyclin D1 is an essential mediator of apoptotic neuronal cell death. , 1996, The EMBO journal.

[30]  L. Guerrini,et al.  Synaptic activation of NF-kappa B by glutamate in cerebellar granule neurons in vitro. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[31]  C. Portera-Cailliau,et al.  Evidence for apoptotic cell death in Huntington disease and excitotoxic animal models , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[32]  I. Faraoni,et al.  HSP70 production and inhibition of cell proliferation in Molt-4 T-cells after cell-to-cell transmission of HTLV-I: effect of PGA1. , 1995, Leukemia research.

[33]  P. Lacal,et al.  Effects of cyclopentenone prostaglandins on myeloid cells during early infection with HTLV-I. II. Regulation of synthesis of inducible p72 heat shock protein. , 1994, The Journal of pharmacology and experimental therapeutics.

[34]  S. Narumiya,et al.  VIII. International union of pharmacology classification of prostanoid receptors: Properties, distribution, and structure of the receptors and their subtypes , 1994 .

[35]  M. Hughes-Fulford,et al.  Cell cycle arrest by prostaglandin A1 at the G1/S phase interface with up‐regulation of oncogenes in S‐49 cyc− cells , 1994, Journal of cellular biochemistry.

[36]  S. Estus,et al.  Analysis of cell cycle-related gene expression in postmitotic neurons: Selective induction of cyclin D1 during programmed cell death , 1994, Neuron.

[37]  D. Latchman,et al.  Heat shock protects neuronal cells from programmed cell death by apoptosis , 1993, Neuroscience.

[38]  D. Lowenstein,et al.  Heat shock protein expression in vulnerable cells of the rat hippocampus as an indicator of excitation-induced neuronal stress , 1992, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[39]  D. Lowenstein,et al.  The stress protein response in cultured neurons: Characterization and evidence for a protective role in excitotoxicity , 1991, Neuron.

[40]  W. Koroshetz,et al.  Heat shock protects cultured neurons from glutamate toxicity , 1991, Neuron.

[41]  F. Dray,et al.  Tumor cell biotransformation products of prostaglandin A1 with growth inhibitory activity. , 1986, Biochemical and biophysical research communications.

[42]  C. Justicia,et al.  Activation of nuclear factor-kappaB in the rat brain after transient focal ischemia. , 1999, Brain research. Molecular brain research.

[43]  T. Chase,et al.  Nuclear factor-kappa B contributes to excitotoxin-induced apoptosis in rat striatum. , 1998, Molecular pharmacology.

[44]  V. Marx,et al.  Inhibition of nuclear factor kB by prostaglandin A1: An effect associated with heat shock transcription factor activation (antiviralyHIVyIkB-aytumor necrosis factor a) , 1997 .

[45]  D. Stephenson,et al.  Global ischemia activates nuclear factor-kappa B in forebrain neurons of rats. , 1997, Stroke.

[46]  P. Baeuerle,et al.  Transcription factor NF-kappaB is activated in primary neurons by amyloid beta peptides and in neurons surrounding early plaques from patients with Alzheimer disease. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[47]  D. Baltimore,et al.  An essential role for NF-kappaB in preventing TNF-alpha-induced cell death. , 1996, Science.

[48]  J. Breitner.  The role of anti-inflammatory drugs in the prevention and treatment of Alzheimer's disease. , 1996, Annual review of medicine.